Biology:Phosphogluconate dehydrogenase

From HandWiki
Revision as of 11:32, 6 February 2023 by Raymond Straus (talk | contribs) (fix)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
6PGD
PDB 1pgq EBI.jpg
Crystallographic structure of sheep 6-phosphogluconate dehydrogenase complexed with adenosine 2'-monophosphate.[1]
Identifiers
Symbol6PGD
PfamPF00393
Pfam clanCL0106
InterProIPR006114
PROSITEPDOC00390
SCOP22pgd / SCOPe / SUPFAM
Phosphogluconate dehydrogenase
Identifiers
EC number1.1.1.44
CAS number9001-82-5
Databases
IntEnzIntEnz view
BRENDABRENDA entry
ExPASyNiceZyme view
KEGGKEGG entry
MetaCycmetabolic pathway
PRIAMprofile
PDB structuresRCSB PDB PDBe PDBsum
Gene OntologyAmiGO / QuickGO
phosphogluconate dehydrogenase
Identifiers
SymbolPGD
NCBI gene5226
HGNC8891
OMIM172200
RefSeqNM_002631
UniProtP52209
Other data
EC number1.1.1.44
LocusChr. 1 p36.3-36.13

6-Phosphogluconate dehydrogenase (6PGD) is an enzyme in the pentose phosphate pathway. It forms ribulose 5-phosphate from 6-phosphogluconate:

6-phospho-D-gluconate + NAD(P)+ [math]\displaystyle{ \rightleftharpoons }[/math] 6-phospho-2-dehydro-D-gluconate + NAD(P)H + H+

It is an oxidative carboxylase that catalyses the decarboxylating reduction of 6-phosphogluconate into ribulose 5-phosphate in the presence of NADP. This reaction is a component of the hexose mono-phosphate shunt and pentose phosphate pathways (PPP).[2][3] Prokaryotic and eukaryotic 6PGD are proteins of about 470 amino acids whose sequences are highly conserved.[4] The protein is a homodimer in which the monomers act independently:[3] each contains a large, mainly alpha-helical domain and a smaller beta-alpha-beta domain, containing a mixed parallel and anti-parallel 6-stranded beta sheet.[3] NADP is bound in a cleft in the small domain, the substrate binding in an adjacent pocket.[3]

Clinical significance

Mutations within the gene coding this enzyme result in 6-phosphogluconate dehydrogenase deficiency, an autosomal hereditary disease affecting the red blood cells.

As a possible drug target

6PGD is involved in cancer cell metabolism so 6PGD inhibitors have been sought.[5]

See also

References

  1. PDB: 1PGQ​; "Crystallographic study of coenzyme, coenzyme analogue and substrate binding in 6-phosphogluconate dehydrogenase: implications for NADP specificity and the enzyme mechanism". Structure 2 (7): 651–68. July 1994. doi:10.1016/s0969-2126(00)00066-6. PMID 7922042. 
  2. "Genetic tagging, cloning, and DNA sequence of the Synechococcus sp. strain PCC 7942 gene (gnd) encoding 6-phosphogluconate dehydrogenase". J. Bacteriol. 172 (7): 4023–31. July 1990. doi:10.1128/jb.172.7.4023-4031.1990. PMID 2113917. 
  3. 3.0 3.1 3.2 3.3 "The three dimensional structure of sheep liver 6-phosphogluconate dehydrogenase at 2.6 A resolution". EMBO J. 2 (6): 1009–14. 1983. doi:10.1002/j.1460-2075.1983.tb01535.x. PMID 6641716. 
  4. "Analysis of the gluconate (gnt) operon of Bacillus subtilis". Mol. Microbiol. 5 (5): 1081–9. May 1991. doi:10.1111/j.1365-2958.1991.tb01880.x. PMID 1659648. 
  5. 6-Phosphogluconate dehydrogenase links oxidative PPP, lipogenesis and tumour growth by inhibiting LKB1–AMPK signalling. 2015
  • "Carbohydrate oxidation by Pseudomonas fluorescens VI. Conversion of 2-keto-6-phosphogluconate to pyruvate". J. Biol. Chem. 236: 2571–2577. 1961. PMID 13894458. 
This article incorporates text from the public domain Pfam and InterPro: IPR006114